These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2957172)
21. Formation of stable crystalline enzyme-substrate intermediates at sub-zero temperatures. Fink AL; Ahmed AI Nature; 1976 Sep; 263(5575):294-7. PubMed ID: 8732 [TBL] [Abstract][Full Text] [Related]
22. [Catalytic properties of plasmin and the equimolar plasmin-streptokinase complex in their reactions with various substrates and inhibitors]. Aĭsina RB; Zhitkova IuV; Fedorenko IaE; Kazanskaia NF Ukr Biokhim Zh (1978); 1991; 63(1):13-20. PubMed ID: 1827550 [TBL] [Abstract][Full Text] [Related]
23. The trypsin-catalyzed hydrolysis of N alpha-benzyloxycarbonyl-L-lysine p-nitrophenyl ester in dimethylsulfoxide at sub-zero temperatures. Fink AL J Biol Chem; 1974 Aug; 249(16):5027-32. PubMed ID: 4855132 [No Abstract] [Full Text] [Related]
24. Activation of pro-urokinase by plasmin: non-Michaelian kinetics indicates a mechanism of negative cooperativity. Scully MF; Ellis V; Watahiki Y; Kakkar VV Arch Biochem Biophys; 1989 Feb; 268(2):438-46. PubMed ID: 2521553 [TBL] [Abstract][Full Text] [Related]
25. [Study of the complex between porcine plasmin and alpha2-macroglobulin (author's transl)]. Jacquot-Armand Y; Guinand S Biochim Biophys Acta; 1976 Jun; 438(1):239-49. PubMed ID: 59608 [TBL] [Abstract][Full Text] [Related]
26. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate. Castro MJ; Kingston IB; Anderson S Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622 [TBL] [Abstract][Full Text] [Related]
27. Allosteric effects of some antifibrinolytic amino acids on the catalytic activity of human plasmin. Christensen U Biochim Biophys Acta; 1978 Sep; 526(1):194-201. PubMed ID: 150862 [TBL] [Abstract][Full Text] [Related]
28. Medium effects on the kinetics of human plasmin. Yang H Thromb Res; 1992 Feb; 65(3):377-88. PubMed ID: 1385909 [TBL] [Abstract][Full Text] [Related]
29. Investigation of the substrate-binding site of human plasmin using tripeptidyl-p-nitroanilide substrates. Szabó G; Pozsgay M; Elödi P Thromb Res; 1980 Oct; 20(2):199-206. PubMed ID: 6451949 [No Abstract] [Full Text] [Related]
30. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound. Wiman B; Wallén P Eur J Biochem; 1973 Jul; 36(1):25-31. PubMed ID: 4270055 [No Abstract] [Full Text] [Related]
31. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex]. Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080 [TBL] [Abstract][Full Text] [Related]
32. Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue. Machovich R; Owen WG Thromb Haemost; 1993 Nov; 70(5):864-6. PubMed ID: 8128447 [TBL] [Abstract][Full Text] [Related]
33. Structural and catalytic response to temperature and cosolvents of carboxylesterase EST1 from the extremely thermoacidophilic archaeon Sulfolobus solfataricus P1. Sehgal AC; Tompson R; Cavanagh J; Kelly RM Biotechnol Bioeng; 2002 Dec; 80(7):784-93. PubMed ID: 12402324 [TBL] [Abstract][Full Text] [Related]
34. Role of protein conformational mobility in enzyme catalysis: acylation of alpha-chymotrypsin by specific peptide substrates. Hengge AC; Stein RL Biochemistry; 2004 Jan; 43(3):742-7. PubMed ID: 14730979 [TBL] [Abstract][Full Text] [Related]
35. N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester: a novel, high selective and optimal chromogenic active site titrant for human and bovine alpha-, beta- and gamma-thrombin. Balliano G; Milla P; Giordano C; Gallina C; Coletta M; Menegatti E; Rizzi M; Bolognesi M; Ascenzi P Biochem Biophys Res Commun; 1996 Aug; 225(2):557-61. PubMed ID: 8753800 [TBL] [Abstract][Full Text] [Related]
36. Dual effect of synthetic plasmin substrates on plasminogen activation. Kolev K; Owen WG; Machovich R Biochim Biophys Acta; 1995 Mar; 1247(2):239-45. PubMed ID: 7696314 [TBL] [Abstract][Full Text] [Related]
37. Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates. Astedt B; Bladh B; Christensen U; Lecander I Scand J Clin Lab Invest; 1985 Sep; 45(5):429-35. PubMed ID: 2930896 [TBL] [Abstract][Full Text] [Related]
38. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation. Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495 [TBL] [Abstract][Full Text] [Related]
39. Specificity of thrombin: evidence for selectivity in acylation rather than binding for p-nitrophenyl alpha-amino-p-toluate. Ryan TJ; Fenton JW; Chang T; Feinman RD Biochemistry; 1976 Mar; 15(6):1337-41. PubMed ID: 130165 [TBL] [Abstract][Full Text] [Related]
40. Modulation of plasminogen activation and plasmin activity by methylglyoxal modification of the zymogen. Léránt I; Kolev K; Gombás J; Machovich R Biochim Biophys Acta; 2000 Jul; 1480(1-2):311-20. PubMed ID: 10899632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]